# Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule

Study · id `cardio:ct-nct02380794` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02380794](<https://clinicaltrials.gov/study/NCT02380794>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02380794

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

## Technical summary

Registry record NCT02380794. Randomized; triple masking; primary purpose treatment. Start 2015-10-28 (actual); primary completion 2017-06-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT02380794, source copy `cardio:ctgov-nct02380794-2019-07-29`, retrieved 2026-10-31)
- Started: 2015-10-28 (actual) (ClinicalTrials.gov record NCT02380794, source copy `cardio:ctgov-nct02380794-2019-07-29`, retrieved 2026-10-31)
- Primary completion: 2017-06-02 (actual) (ClinicalTrials.gov record NCT02380794, source copy `cardio:ctgov-nct02380794-2019-07-29`, retrieved 2026-10-31)
- Completion: 2017-06-02 (actual) (ClinicalTrials.gov record NCT02380794, source copy `cardio:ctgov-nct02380794-2019-07-29`, retrieved 2026-10-31)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT02380794, source copy `cardio:ctgov-nct02380794-2019-07-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02380794-2019-07-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
- Condition: Peripheral Arterial Disease
- Condition: Intermittent Claudication
- Intervention (Drug): Danshen Gegen Capsule
- Intervention (Drug): Placebo
- Lead sponsor: Chinese University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Chinese University of Hong Kong (`cardio:org-chinese-university-of-hong-kong`)

## Provenance

Content hash: fd3f624067b0b83dddf5cfab35d5eae75932b3020f84f975fcc9688612de5b4c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
